Acute lymphoblastic leukaemia has a poor outcome in children with Down syndrome due to infective death in remission - (Results of UK MRC ALL 97 trial).

被引：0
|
作者：
de la Fuente, J
Richards, S
Webb, DK
Hann, IM
Mitchell, CD
Vora, AJ
Kinsey, SE
Eden, OB
Ancliff, P
机构：
[1] Great Ormond St Hosp Children, Dept Haematol, London WC1N 3JH, England
[2] CTSU, Oxford, England
[3] John Radcliffe Hosp, Oxford OX3 9DU, England
[4] Sheffield Childrens Hosp, Dept Haematol, Sheffield S10 2TH, S Yorkshire, England
[5] St James Univ Hosp, Dept Paediat Oncol, Leeds LS9 7TF, W Yorkshire, England
[6] Christie Hosp, Acad Unit Paediat Oncol, Manchester, Lancs, England
来源：
BLOOD | 2005年 / 106卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
873
引用
收藏
页码：256A / 257A
页数：2
相关论文
共 50 条
  • [21] The thiopurine methyltransferase TPMT *1/*3A genotype is associated with a better treatment outcome in the UK ALL97 trial for childhood acute lymphoblastic leukaemia; TPMT heterozygosity is not associated with secondary cancers
    Lennard, Lynne
    Cartwright, Cher
    Wade, Rachel
    Richards, Sue
    Mitchell, Chris
    Kinsey, Sally
    Eden, Tim
    Lilleyman, John
    Vora, Ajay
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 70 (02) : 298 - 299
  • [22] Early response to induction is predictive of survival in childhood Philadelphia chromosome positive acute lymphoblastic leukaemia: Results of the Medical Research Council ALL 97 trial.
    Roy, A
    Bradburn, M
    Moorman, AV
    Burrett, J
    Mitchell, C
    Kinsey, SE
    Vora, AJ
    Lilleyman, J
    Eden, O
    Hann, I
    Saha, V
    BLOOD, 2004, 104 (11) : 51A - 51A
  • [23] Effect of mitoxantrone on outcome of children with first relapse of acute lymphoblastic leukaemia (ALL R3): an open-label randomised trial
    Parker, Catriona
    Waters, Rachel
    Leighton, Carly
    Hancock, Jeremy
    Sutton, Rosemary
    Moorman, Anthony V.
    Ancliff, Philip
    Morgan, Mary
    Masurekar, Ashish
    Goulden, Nicholas
    Green, Nina
    Revesz, Tamas
    Darbyshire, Philip
    Love, Sharon
    Saha, Vaskar
    LANCET, 2010, 376 (9757): : 2009 - 2017
  • [24] Philadelphia chromosome plus ve patients with adult acute lymphoblastic leukaemia (ALL), early results from the international ALL trial (MRC UKALL-XII/ECOG E2993).
    Goldstone, AH
    Richards, S
    Wiernik, PH
    Franklin, IM
    Burnett, AK
    Lazarus, HM
    Prentice, HG
    Neuberg, D
    Tallman, MS
    Harrison, G
    Rowe, JM
    BLOOD, 1999, 94 (10) : 694A - 694A
  • [25] Primary prophylaxis with voriconazole in patients receiving induction chemotherapy on the MRC adult acute lymphoblastic leukaemia trial (UK-ALL XII) to avoid itraconazole-enhanced vinca neurotoxicity
    Whittle, A. M.
    Ali, S.
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2008, 30 (02) : 173 - 174
  • [26] Efficacy and Toxicity of Pegylated Asparaginase in the Treatment of Children and Young Adults with Acute Lymphoblastic Leukaemia: Results of the United Kingdom Medical Research Council (MRC) Trial UKALL 2003
    Vora, Aiay
    Wade, Rachel
    Mitchell, Christopher
    Goulden, Nicholas
    Richards, Sue
    BLOOD, 2008, 112 (11) : 337 - 337
  • [27] Allogeneic bone marrow transplantation (BMT) for adults with acute lymphoblastic leukemia (ALL) in first complete remission (CR): Early results from the international all trial (MRC UKALL XII/ECOG E2993).
    Rowe, JM
    Richards, S
    Wiernik, PH
    Franklin, IM
    Burnett, AK
    Lazarus, HM
    Prentice, HG
    Harrison, G
    Neuberg, D
    Tallman, MS
    Goldstone, AH
    BLOOD, 1999, 94 (10) : 168A - 168A
  • [28] Allogeneic transplant (related or unrelated donor) is the preferred treatment for adult Philadelphia chromosome positive (Ph plus) acute lymphoblastic leukaemia (ALL). Results from the international ALL trial (MRC UKALLXII/ECOG E2993).
    Goldstone, AH
    Prentice, HG
    Durrant, J
    Franklin, IM
    Harrison, G
    Richards, SM
    Lazarus, HM
    Wiernik, PH
    Tallman, MS
    Rowe, JM
    BLOOD, 2001, 98 (11) : 856A - 856A
  • [29] Clinical characteristics and treatment outcome of children with acute lymphoblastic leukemia (ALL) and Down syndrome (DS): Follow-up of the children's cancer group (CCG) cohort.
    Bhatia, S
    Sather, HN
    Trigg, M
    Gaynon, PS
    Robison, LL
    James, WA
    BLOOD, 2001, 98 (11) : 719A - 719A
  • [30] Prognostic effect of chromosomal abnormalities in childhood B-cell precursor acute lymphoblastic leukaemia: results from the UK Medical Research Council ALL97/99 randomised trial. (vol 11, pg 429, 2010)
    Moorman, A., V
    Ensor, H. M.
    Richards, S. M.
    LANCET ONCOLOGY, 2010, 11 (06): : 516 - 516
12345